NCT02982603View on ClinicalTrials.gov

Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Mild Cognitive ImpairmentHerbal Medicine Allergy
Interventions
DRUG

Qinggongshoutao Bolus

Qinggongshoutao bolus and placebo identified to Ginkgo Biloba Extract 761

DRUG

Ginkgo Biloba Extract 761

Placebo identified to Qinggongshoutao bolus and Ginkgo Biloba Extract 761

DRUG

Placebos

Placebo identified to Qinggongshoutao Bolus and placebo identified to Ginkgo biloba

Trial Locations (1)

100700

Dongzhimen Hospital ,Beijing University of Chinese Medicine, Beijing

All Listed Sponsors
lead

Dongzhimen Hospital, Beijing

OTHER

NCT02982603 - Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter